Palvella Therapeutics Inc
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Palvella Therapeutics Inc
Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company’s lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company’s patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.
/ 
Frequently asked questions
To buy Palvella Therapeutics Inc stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Palvella Therapeutics Inc by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Palvella Therapeutics Inc is PVLA:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Palvella Therapeutics Inc has its primary listing on NASDAQ (Small cap). You can trade Palvella Therapeutics Inc with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Palvella Therapeutics Inc is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Palvella Therapeutics Inc as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Palvella Therapeutics Inc.